01.31.23
La Roche-Posay was the fastest growing skincare brand in 2022. According to NielsenIQ, the brand ranked first among top 30 brands based in dollar and unit sales growth (46%, 48% respectively) for full-year 2022 vs. full-year 2021.
"Thank you to our partners who have helped build and support the La Roche-Posay business. We deeply appreciate your hard work and dedication in helping La Roche-Posay reach this incredible achievement, including dermatologists, nurses, medical staff, pharmacists, editors, retailers, agencies, and of course, the brand team,” said Penelope Giraud, La Roche-Posay USA, General Manager. “Our brand has always been confident in the strength and efficacy of our products. We are thrilled about the US consumer's growing interest in our life-changing dermatologist-backed skincare.”
This achievement was also supported through various key programs and initiatives that La Roche-Posay executed throughout 2022, including:
"Thank you to our partners who have helped build and support the La Roche-Posay business. We deeply appreciate your hard work and dedication in helping La Roche-Posay reach this incredible achievement, including dermatologists, nurses, medical staff, pharmacists, editors, retailers, agencies, and of course, the brand team,” said Penelope Giraud, La Roche-Posay USA, General Manager. “Our brand has always been confident in the strength and efficacy of our products. We are thrilled about the US consumer's growing interest in our life-changing dermatologist-backed skincare.”
This achievement was also supported through various key programs and initiatives that La Roche-Posay executed throughout 2022, including:
- The annual SOS - Save Our Skin campaign, a decade-long public health awareness and educational campaign to inform Americans about the dangers of UV and the importance of daily sun safety.
- A new partnership with the American Cancer Society to further the support of cancer patients, survivors, caregivers, and the oncology community as well as raise awareness of the skin side effects of cancer treatments.
- A partnership with the Women's Dermatologic Society (WDS) for a collaboration to sponsor a Fellowship in the Department of Dermatology at Howard University's College of Medicine for UIM.
- Sponsoring the Skin of Color and Pigmentary Disorders Research Fellowship at the Keck School of Medicine of University of Southern California (USC)